India overtakes Iran in clinical trial initiations outside North America and Europe in Q2 2025 Read more
Baxdrostat met primary, secondary endpoints in BaxHTN Phase III trial in patients with treatment-resistant hypertension Read more
Session 22 of FOPE, PharmaState Academy’s PULSE Program drives compliance excellence in OSD manufacturing under Revised Schedule M Read more
Session 21 of FOPE, PharmaState Academy’s PULSE Program, advances excellence in manufacture of APIs under revised schedule M Read more